400 related articles for article (PubMed ID: 23467287)
1. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
[TBL] [Abstract][Full Text] [Related]
2. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
[TBL] [Abstract][Full Text] [Related]
3. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
4. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome.
Bran GM; Börjesson PKE; Boahene KD; Gosepath J; Lohuis PJFM
Plast Reconstr Surg; 2014 Jan; 133(1):121-129. PubMed ID: 24105091
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin Type A Injection in the Treatment of Postparetic Facial Synkinesis: An Integrative Review.
Tavares H; Oliveira M; Costa R; Amorim H
Am J Phys Med Rehabil; 2022 Mar; 101(3):284-293. PubMed ID: 35175961
[TBL] [Abstract][Full Text] [Related]
8. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
Wei LA; Diels J; Lucarelli MJ
Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
[TBL] [Abstract][Full Text] [Related]
9. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
Terzis JK; Karypidis D
J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
[TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
Hjelm N; Crippen M; Azizzadeh B
Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
[No Abstract] [Full Text] [Related]
15. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
Terzis JK; Karypidis D
Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous cooling to manage botulinum toxin injection-associated pain in patients with facial palsy: A randomised controlled trial.
Pucks N; Thomas A; Hallam MJ; Venables V; Neville C; Nduka C
J Plast Reconstr Aesthet Surg; 2015 Dec; 68(12):1701-5. PubMed ID: 26385134
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
Yücel OE; Artürk N
Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
[TBL] [Abstract][Full Text] [Related]
19. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
Neville C; Venables V; Aslet M; Nduka C; Kannan R
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years.
Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R
Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
